Showing 641 - 660 results of 693 for search '"Parkinson's disease"', query time: 0.06s Refine Results
  1. 641

    Measuring Measuring iron concentration in the blood samples of some autistic children from Baghdad City by Ezzuldin sulaiman, Hind Suhail Abdulhay

    Published 2025-01-01
    “…Iron is one of the heavy metals around which there is much controversy regarding their role as neurotoxins in the development of autism, its excess in the brain may cause Alzheimer's disease or Parkinson's disease, while iron deficiency in the blood may increase levels of other heavy metals in the blood and brain, such as cadmium and lead. …”
    Get full text
    Article
  2. 642

    Procedural Memory: Computer Learning in Control Subjects and in Parkinson’s Disease Patients by C. Thomas-Antérion, B. Laurent, N. Foyatier-Michel, S. Laporte, D. Michel

    Published 1996-01-01
    “…We also studied 24 patients with Parkinson's disease (PD). We observed an influence of age and also of educational levels. …”
    Get full text
    Article
  3. 643

    Cannabis oil in treating Parkinson’s disease: improvement of motor and non-motor symptoms: a case report by C. T. M. I. Issa, R. D. Castro, K. L. G. D. Albuquerque

    Published 2025-01-01
    “…These compelling results suggest that cannabis oil may offer a valuable and effective therapeutic option for individuals with Parkinson's disease.…”
    Get full text
    Article
  4. 644

    EFFECT OF Zanthoxylum acanthopodium DC EXTRACT ON THE INCREASE OF BRAIN CELLS IN THE SUBSTANTIA NIGRA OF WISTAR RATS THAT ARE ROTENONE-INDUCED by Shalli hafizha, Binarwan Halim, Linda Chiuman

    Published 2024-12-01
    “… Parkinson's disease (PD) is a neurodegenerative disorder due to the decline of dopaminergic neurons in the substantia nigra, with motor and non-motor symptoms. …”
    Get full text
    Article
  5. 645

    Multicomponent reactions driving the discovery and optimization of agents targeting central nervous system pathologies by Lucía Campos-Prieto, Aitor García-Rey, Eddy Sotelo, Ana Mallo-Abreu

    Published 2024-12-01
    “…In this review, we focus on central nervous system (CNS) disorders, particularly Alzheimer's disease, Parkinson's disease, schizophrenia, depression, and epilepsy, where MCRs have contributed to the development of promising ligands in recent years. …”
    Get full text
    Article
  6. 646

    Microglia-secreted TNF-α affects differentiation efficiency and viability of pluripotent stem cell-derived human dopaminergic precursors. by Shirley D Wenker, María Isabel Farias, Victoria Gradaschi, Corina Garcia, Juan Beauquis, María Celeste Leal, Carina Ferrari, Xianmin Zeng, Fernando J Pitossi

    Published 2023-01-01
    “…Finally, Tumour necrosis factor alpha plays a key role in these effects, suggesting that this cytokine could be an interesting target to increase the efficacy of human dopaminergic precursors transplantation in Parkinson's Disease.…”
    Get full text
    Article
  7. 647

    Decision Making under Risk Condition in Patients with Parkinson’s Disease: A Behavioural and fMRI Study by Kirsten Labudda, Matthias Brand, Markus Mertens, Isabelle Ollech, Hans J. Markowitsch, Friedrich G. Woermann

    Published 2010-01-01
    “…We aimed to study whether previously described impairment in decision making under risky conditions in patients with Parkinson's disease (PD) is affected by deficits in using information about potential incentives or by processing feedback (in terms of fictitious gains and losses following each decision). …”
    Get full text
    Article
  8. 648

    More than just a number: the gut microbiota and brain function across the extremes of life by Nathan D. Nuzum, Clara Deady, Sarah Kittel-Schneider, John F. Cryan, Siobhain M. O'Mahony, Gerard Clarke

    Published 2024-12-01
    “…In neurodegeneration research, strong causal evidence now links the gut microbiome to Alzheimer's (AD), and Parkinson's Disease (PD), as supported by human-to-animal transplantation studies. …”
    Get full text
    Article
  9. 649

    Dendrobium species regulate energy homeostasis in neurodegenerative diseases: a review by Feixuan Wang, Jingqiong Wan, Yangzhen Liao, Shangyu Liu, Yuan Wei, Zhen Ouyang

    Published 2023-11-01
    “…Furthermore, they reduce neurotoxicity, alleviate brain injury and neuropathy, and prevent neurodegenerative conditions including stroke, Alzheimer's disease, Parkinson's disease, and Huntington's disease in humans and/or rodents. …”
    Get full text
    Article
  10. 650

    Applications of Ultrasonic Brain Imaging and Transcranial Ultrasound Therapy in Brain Injury Rehabilitation by WU Yi

    Published 2023-04-01
    “…High intensity focused ultrasound (HIFU) and low intensity focused ultrasound (LIFU) use the thermal and mechanical effects respectively to perform tissue ablation, blood-brain barrier opening, drug targeted delivery, ultrasound-assisted catheter-directed thrombolysis and neuromodulation, and can be applied to the treatment of brain tumors, brain trauma, stroke, Parkinson's disease, Alzheimer's disease, epilepsy, depression and other neurological diseases and mental diseases. …”
    Get full text
    Article
  11. 651

    Superfoods and their impact on brain health: a systematic review by Raghupathi Niranjan Kumar, Haja Nazeer Ahamed

    Published 2025-01-01
    “…Abstract Aim of the study This review examines the pharmacology and clinical applications of superfoods like Crocus sativus, Murraya koenigii, Phoenix dactylifera, Punica granatum, Ficus carica, and Beta vulgaris on mental health, anxiety, depression, schizophrenia, Alzheimer's disease, cognitive decline, psychosis, Parkinson's disease, and stroke. We hope this perspective guides superfood research. …”
    Get full text
    Article
  12. 652

    Diet and medical foods in Parkinson’s disease by Klaus W. Lange, Yukiko Nakamura, Ning Chen, Jianjun Guo, Shigehiko Kanaya, Katharina M. Lange, Shiming Li

    Published 2019-06-01
    “…Parkinson's disease (PD) is a slowly progressive neurodegenerative disorder with motor and non-motor signs, which begins long before the diagnosis can be made. …”
    Get full text
    Article
  13. 653

    Hippocampal Proliferation Is Increased in Presymptomatic Parkinson’s Disease and due to Microglia by Karlijn J. Doorn, Benjamin Drukarch, Anne-Marie van Dam, Paul J. Lucassen

    Published 2014-01-01
    “…Besides dopamine-deficiency related motor symptoms, nonmotor symptoms, including cognitive changes occur in Parkinson's disease (PD) patients, that may relate to accumulation of α-synuclein in the hippocampus (HC). …”
    Get full text
    Article
  14. 654

    Remission of Cognitive Deficits in Parkinson’s Disease: Recovery from a Nonamnestic Mild Cognitive Impairment or Psychiatric Symptoms Remission? by Jonas Jardim de Paula, Marco Túlio Gualberto Cintra, Débora Marques Miranda, Maria Aparecida Camargos Bicalho, Edgar Nunes Moares, Leandro Fernandes Malloy-Diniz

    Published 2012-01-01
    “…Mild cognitive impairment is a clinical condition more frequent in patients with Parkinson's disease than in general population. The nonamnestic presentations, usually characterized by executive dysfunction, are most prevalent. …”
    Get full text
    Article
  15. 655

    Dietary L-proline supplementation ameliorates autism-like behaviors and modulates gut microbiota in the valproic acid-induced mouse model of autism spectrum disorder by Jingjing Fang, Ruixuan Geng, Seong-Gook Kang, Kunlun Huang, Tao Tong

    Published 2024-09-01
    “…RNA sequencing demonstrated that Pro can also alter the PFC transcriptomic profile distinguished by the regulation of genes involved in Parkinson disease, neuroactive ligand-receptor interaction, oxidative phosphorylation, and mitogen activated protein kinase signaling pathway. …”
    Get full text
    Article
  16. 656

    Alpha synuclein overexpression can drive microbiome dysbiosis in mice by Timothy R. Sampson, Zachary D Wallen, Woong-Jai Won, David G. Standaert, Haydeh Payami, Ashley S. Harms

    Published 2025-02-01
    “…Abstract Growing evidence indicates that persons with Parkinson disease (PD), have a unique composition of indigenous gut microbes. …”
    Get full text
    Article
  17. 657

    The Effects of Multimodal Exercise Program on Functional Capacity and Quality of Life in Elderly Patients with Parkinson\'s Disease by Abbas Abdel Amir Nasser, khosro Jalali Dehkordi, Mahmoud Nasser Radhi, Farzaneh Taghian, Ahmad Chitsaz

    Published 2024-12-01
    “…Introduction: Parkinson's disease (PD) is a degenerative neurological illness characterized by various motor and non-motor symptoms that can lead to varying degrees of functional impairment. …”
    Get full text
    Article
  18. 658

    CASE REPORT ON TWO CONSECUTIVE PATIENTS WITH NEUROINVASIVE WEST NILE VIRUS INFECTION IN AN INTENSIVE CARE UNIT by Silviya Stoyanova, Raynichka Mihaylova-Garnizova, Emilia Naseva, Severina Dakova, Iva Christova, Konstantin Ramshev

    Published 2025-01-01
    “…The first case was a 60-year-old man who have had mental status changes, fever, and progression of existing Parkinson's disease. Antibodies to WNV were present in cerebrospinal fluid (CSF). …”
    Get full text
    Article
  19. 659

    Therapeutic potential of phytocompounds of Bacopa monnieri (L.) Wettst (literature review) by O.O. Nikitina, D.S. Tsyba

    Published 2024-10-01
    “…Numerous clinical trials show the effectiveness of the use of extracts in the treatment of anhedonia, depression, Alzheimer's disease, Parkinson's disease, dementia and hyperactivity. An analysis of clinical studies in Ukraine shows that drugs based on B. monnieri can be used in the complex treatment of cognitive impairment associated with dyscirculatory encephalopathy in adults and perinatal CNS damage in children. …”
    Get full text
    Article
  20. 660

    New perspectives on the glymphatic system and the relationship between glymphatic system and neurodegenerative diseases by Yan-rui Sun, Qian-Kun Lv, Jun-Yi Liu, Fen Wang, Chun-Feng Liu

    Published 2025-02-01
    “…It discusses the potential roles of the glymphatic system in ND, including Alzheimer's disease (AD), Parkinson's disease (PD), and multiple system atrophy (MSA), and proposes the glymphatic system as a novel therapeutic target for these conditions.…”
    Get full text
    Article